Insider Stock Trading History of Johnston David Brannon


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Johnston David Brannon since year 2005. The trader's CIK number is 1486519. At the time of this reporting, Johnston David Brannon is the Chief Financial Officer of Immunogen Inc . (stock ticker symbol IMGN). See this page for all insider trading activities at Immunogen Inc .

Note that in the past Johnston David Brannon also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Johnston David Brannon since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-11-02 IMGN Immunogen Inc Buy 10,000 1.70 16,980
2015-09-17 IMGN Immunogen Inc Option Ex 5,000 10.79 53,949
2015-09-17 IMGN Immunogen Inc Sale 5,000 15.00 75,000
2015-08-03 IMGN Immunogen Inc Option Ex 5,000 10.79 53,949
2015-08-03 IMGN Immunogen Inc Sale 5,000 17.04 85,180
2013-03-14 AVEO Aveo Pharmaceuticals Inc Sale 1,061 7.34 7,784
2013-01-28 AVEO Aveo Pharmaceuticals Inc Sale 1,150 7.77 8,936
2012-09-13 AVEO Aveo Pharmaceuticals Inc Sale 1,386 10.60 14,695
2012-06-06 AVEO Aveo Pharmaceuticals Inc Option Ex 15,000 5.60 84,000
2012-06-06 AVEO Aveo Pharmaceuticals Inc Sale 15,000 12.21 183,150
2012-01-26 AVEO Aveo Pharmaceuticals Inc Sale 1,107 13.37 14,796
2011-12-01 AVEO Aveo Pharmaceuticals Inc Option Ex 1,000 5.60 5,600
2011-12-01 AVEO Aveo Pharmaceuticals Inc Sale 1,000 16.74 16,737
2011-11-01 AVEO Aveo Pharmaceuticals Inc Sale 2,000 15.44 30,878
2011-11-01 AVEO Aveo Pharmaceuticals Inc Option Ex 2,000 5.60 11,200
2011-10-03 AVEO Aveo Pharmaceuticals Inc Sale 2,000 15.43 30,868
2011-10-03 AVEO Aveo Pharmaceuticals Inc Option Ex 2,000 5.60 11,200
2011-09-01 AVEO Aveo Pharmaceuticals Inc Option Ex 2,000 5.60 11,200
2011-09-01 AVEO Aveo Pharmaceuticals Inc Sale 2,000 16.87 33,748
2011-08-24 AVEO Aveo Pharmaceuticals Inc Sale 1,906 16.43 31,315

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Johnston David Brannon (Chief Financial Officer of Immunogen Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.